ICU Medical (ICUI) Director Sells $1,939,261.20 in Stock

ICU Medical (NASDAQ:ICUI) Director George A. Lopez sold 7,640 shares of ICU Medical stock in a transaction on Wednesday, March 21st. The stock was sold at an average price of $253.83, for a total transaction of $1,939,261.20. Following the completion of the sale, the director now owns 526,574 shares of the company’s stock, valued at approximately $133,660,278.42. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this hyperlink.

Shares of ICU Medical stock traded down $2.65 during trading hours on Thursday, hitting $249.95. 40,526 shares of the company were exchanged, compared to its average volume of 136,591. The company has a market capitalization of $5,118.56, a price-to-earnings ratio of 75.71, a PEG ratio of 2.55 and a beta of 0.42. ICU Medical has a fifty-two week low of $144.25 and a fifty-two week high of $265.27.

How to Become a New Pot Stock Millionaire

ICU Medical (NASDAQ:ICUI) last issued its quarterly earnings results on Thursday, March 1st. The medical instruments supplier reported $2.98 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $1.04 by $1.94. The business had revenue of $370.12 million during the quarter, compared to analyst estimates of $332.91 million. ICU Medical had a net margin of 5.31% and a return on equity of 8.42%. The business’s revenue was up 286.8% compared to the same quarter last year. During the same quarter in the previous year, the firm earned $1.20 earnings per share. equities analysts predict that ICU Medical will post 6.29 earnings per share for the current year.

A number of hedge funds have recently added to or reduced their stakes in the business. BlackRock Inc. increased its stake in ICU Medical by 3.4% during the fourth quarter. BlackRock Inc. now owns 1,879,874 shares of the medical instruments supplier’s stock valued at $406,052,000 after purchasing an additional 62,605 shares during the last quarter. Janus Henderson Group PLC increased its stake in ICU Medical by 17.6% during the third quarter. Janus Henderson Group PLC now owns 1,684,094 shares of the medical instruments supplier’s stock valued at $312,989,000 after purchasing an additional 251,793 shares during the last quarter. Wells Fargo & Company MN increased its stake in ICU Medical by 0.9% during the third quarter. Wells Fargo & Company MN now owns 560,756 shares of the medical instruments supplier’s stock valued at $104,217,000 after purchasing an additional 5,044 shares during the last quarter. JPMorgan Chase & Co. increased its stake in ICU Medical by 3.5% during the third quarter. JPMorgan Chase & Co. now owns 432,281 shares of the medical instruments supplier’s stock valued at $80,122,000 after purchasing an additional 14,537 shares during the last quarter. Finally, Eagle Asset Management Inc. increased its stake in ICU Medical by 2.3% during the third quarter. Eagle Asset Management Inc. now owns 194,839 shares of the medical instruments supplier’s stock valued at $36,629,000 after purchasing an additional 4,330 shares during the last quarter. Hedge funds and other institutional investors own 77.30% of the company’s stock.

A number of brokerages recently issued reports on ICUI. BidaskClub upgraded shares of ICU Medical from a “hold” rating to a “buy” rating in a research note on Wednesday, March 7th. Zacks Investment Research upgraded shares of ICU Medical from a “hold” rating to a “buy” rating and set a $266.00 price target for the company in a research note on Tuesday, January 23rd. Two analysts have rated the stock with a hold rating and three have assigned a buy rating to the company. ICU Medical currently has a consensus rating of “Buy” and an average target price of $266.00.

ILLEGAL ACTIVITY WARNING: “ICU Medical (ICUI) Director Sells $1,939,261.20 in Stock” was reported by Ticker Report and is the property of of Ticker Report. If you are reading this story on another website, it was illegally copied and reposted in violation of international trademark and copyright laws. The correct version of this story can be viewed at https://www.tickerreport.com/banking-finance/3289350/icu-medical-icui-director-sells-1939261-20-in-stock.html.

ICU Medical Company Profile

ICU Medical, Inc develops, manufactures, and sells medical devices used in infusion therapy, critical care, and oncology applications worldwide. It offers infusion therapy products comprising a tube running from a bottle or plastic bag containing a solution to a catheter inserted in a patient's vein for use in hospitals and ambulatory clinics.

Insider Buying and Selling by Quarter for ICU Medical (NASDAQ:ICUI)

Receive News & Ratings for ICU Medical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for ICU Medical and related companies with MarketBeat.com's FREE daily email newsletter.

Latest News

Valeura Energy  Insider Sells C$1,580,806.08 in Stock
Valeura Energy Insider Sells C$1,580,806.08 in Stock
Robert Half International  Trading 0.3% Higher  on Analyst Upgrade
Robert Half International Trading 0.3% Higher on Analyst Upgrade
Texas Instruments  Shares Gap Up  on Analyst Upgrade
Texas Instruments Shares Gap Up on Analyst Upgrade
Samuel Adams  Hits New 1-Year High and Low After Strong Earnings
Samuel Adams Hits New 1-Year High and Low After Strong Earnings
Peoples Financial Services  Announces  Earnings Results
Peoples Financial Services Announces Earnings Results
Tupperware Brands  Issues Q2 Earnings Guidance
Tupperware Brands Issues Q2 Earnings Guidance


© 2006-2018 Ticker Report. Google+.